- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05668611
Train the Trainer Curriculum to Scale up AI Supported Echo for RHD Screening in a Public Health System (ADD-RHD 2B)
Design and Evaluation of a Train the Trainer Curriculum to Scale Up Automated Intelligence Supported Echocardiography for Rheumatic Heart Disease Screening in a Public Health Care System
Study Overview
Status
Conditions
Detailed Description
Objective 1:
4 ultrasound naïve nurses (Primary) employed at the HCIII/IVs participating in ADD-RHD Part 1 (SOMREC REF 2021-61) in Lira, will be trained and certified by experts in echocardiography for RHD on focused RHD echocardiographic screening examination and interpretation using a novel AI guided software.
Focused RHD screening echocardiograms by the 4 nurses will be integrated into routine clinical practice at their assigned HCIII/IVs for 1 month.
Screen positive patients will be referred to LRRH for confirmatory echocardiogram using a Standard echocardiographic machine under the National RHD registry (SOMREC REF 2014-137).
All echocardiograms will be uploaded to a secure cloud-based server and over-read by a cardiologist with in one - two (1 - 2) weeks to ensure patient safety and to determine trainee performance.
Diagnostic accuracy, sensitivity, specificity, positive and negative predictive values will be calculated.
4 MOH trainees will use pre-recorded PowerPoint presentations to conduct hands-on training for phase 2 (secondary) nurses.
Objective 2:
Similar to Phase 1 with just a few exceptions. 12 MOH nurses will be trained and certified by MOH nurse trainers from phase 1 to acquire and interpret RHD focused screening echocardiograms using a novel AI guided software.
Screening will be integrated into routine care for 2 months and diagnostic performance assessed.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Kampala, Uganda
- Uganda Heart Institute
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Attend same HCIII/IV sites that the MOH nurses work at
- Agree to participate via the study's informed consent
Exclusion Criteria:
- Very sick participants requiring transfer to higher level facility or inpatient care
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Primary Training
4 Ministry of Health nurses will be trained by expert trainers to become certified in focused echocardiography acquisition and interpretation in order to screen patients for rheumatic heart diseases
|
A four-day training program taken over the course of two weekends will include materials on RHD and RHD echocardiographic screening using focused artificial intelligence navigational guided echocardiographic acquisition to identify patients who are screen positive or screen negative for RHD.
The echo protocol will be limited to the parasternal long axis-view (2D and color Doppler) focusing on mitral and aortic valve morphology and function and a single 2D apical 4 chamber view for auto EF.
The curriculum package will include online modules, instructor delivered PowerPoint presentations, and hands on practice on volunteers with and without RHD.
A pre- and post-training test on RHD knowledge and diagnosis will be administered.
A rapid competency assessment, including obtaining imaging on volunteers with or without RHD and an online test with pre-recorded cases of RHD, LV dysfunction and Pericardial effusions, will be utilized at the end of the 4-day training sessions.
Trainees will be monitored by trained study personnel and at the end of the practicum training, the expert users will blindly review and assess the quality of each study using the standardized scale and competency scorecard provided below.
Additionally, they will be asked to pass the knowledge quiz (80% or better).
If competency is not achieved, an additional weekend of training can be added.
Following certification, the certified MOH nurses will integrate echocardiographic screening into the routine workflow at the 4 HCIII/IV clinics with each nurse carrying out screening at the assigned HC on patients (aged 5-40) presenting to the health center for routine care. Screening will be done daily over a period of one month. A minimum total of 400 participants will be screened during this period; each nurse will screen as many patients as they can, with a minimum of 100 participants (at least 5 participants per day). At the end of each screen, the trainees will interpret the screen as screen negative or screen positive. They will go ahead to refer participants identified as screen positives to the district hospital (LRRH) for a confirmatory echo. At the end of each screening day, all images will be uploaded to a cloud server for a confirmatory review by a cardiology fellow or cardiology attending physician, within in 1 - 2 weeks. |
|
Experimental: Secondary Training
The 4 Ministry of Health nurses trained in Aim 1 will then train and certify 3 other nurses from their clinics in focused echocardiography acquisition interpretation.
|
Each Primary Trained MOH Nurse will train 3 other nurses from their Health Center using pre-recorded PowerPoints.
The secondarily trained nurses will be assessed and certified by the nurse trainer.
Following certification, the certified MOH nurses will integrate echocardiographic screening into the routine workflow at the 4 HCIII/IV clinics with each nurse carrying out screening at the assigned HC on patients (aged 5-40) presenting to the health center for routine care. Screening will be done daily over a period of two months. A minimum total of 1200 participants will be screened during this period; each nurse will screen as many patients as they can, with a minimum of 100 participants. At the end of each screen, the trainees will interpret the study as screen negative or screen positive. They will go ahead to refer participants identified as screen positives to the district hospital (LRRH) for a confirmatory echo. At the end of each screening day, all images will be uploaded to a cloud server for a confirmatory review by a cardiology fellow or cardiology attending physician, within in 1 - 2 weeks. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
RHD Echocardiographic Diagnostic accuracy, sensitivity, specificity of MOH nurses
Time Frame: 2 months after completion of training
|
Diagnostic performance of MOH nurses who have completed certification in focused echocardiography acquisition and interpretation by expert trainers will be assessed.
Diagnostic accuracy, sensitivity, specificity, positive and negative predictive values will be calculated to determine diagnostic performance of MOH nurses who have completed certification on focused echocardiography acquisition and interpretation.
The ability of trainees to correctly identify screen positive and negative patients for RHD using known expert diagnosis as the reference.
Correct determination of RHD screen positive/negative in at least 80% of cases is the benchmark
|
2 months after completion of training
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Knowledge Assessment
Time Frame: Immediately before the training session and immediately after completion of training
|
Questionnaire to test compare pre and post training knowledge about Rheumatic Heart Disease administered to nurse trainees.
|
Immediately before the training session and immediately after completion of training
|
|
Computer Based Testing
Time Frame: Immediately following training
|
Computer based testing designed to determine positive and negative screening referrals of patients with RHD and other cardiac diseases
|
Immediately following training
|
|
Rapid Competency assessment
Time Frame: Immediately following training
|
This assessment will be administered post training to nurse trainees.
It is an observation- based assessment designed to assess correct use of the technology, basic image acquisition proficiency, diagnostic accuracy and image quality.
|
Immediately following training
|
|
Provider satisfaction
Time Frame: Immediately post training
|
Surveys questions on training and screening experience along with guided discussions on the training and screening experiences will be administered to nurse trainees
|
Immediately post training
|
|
Longitudinal Image Quality
Time Frame: Daily assessment for 1 month
|
Expert Echocardiographers will access each image acquired by nurses using the ACEP scale.
A scale of 1-5 (1) being no recognizable structure and (5) being excellent image quality of all structures.
A score of 3 and above will be considered diagnostic.
|
Daily assessment for 1 month
|
|
Provider confidence
Time Frame: Daily assessment for 1 month
|
Nurses will subjectively report their level of confidence regarding image quality.
The levels of confidence will be assessed.
(1) Very confident, image quality is good and adequate for diagnosis.
(2) Fairly confident, image is good but confirmation of diagnosis by expert trainer needed, (3) Not confident, image quality not adequate.
|
Daily assessment for 1 month
|
|
Diagnostic performance for other common categories of cardiac diseases
Time Frame: Through completion of screening phase, average of 1 month
|
Assess nurse's ability to accurately identify left ventricular dysfunction and pericardial effusion as compared to the same standard applied by an expert.
|
Through completion of screening phase, average of 1 month
|
|
Time to certification
Time Frame: Trough first day of training to study completion, average of 1 year
|
Determine the time from the first day of training to certification for participants including remediation time.
|
Trough first day of training to study completion, average of 1 year
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Andrea Z Beaton, Children's Hospital Medical Center, Cincinnati
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022-0312
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rheumatic Heart Disease
-
Children's Hospital Medical Center, CincinnatiUganda Heart InstituteCompletedRheumatic Heart Disease in Children | Heart Disease, ValvularUganda
-
Children's National Research InstituteUniversity of Cape Town; Thrasher Research Fund; Murdoch Childrens Research Institute and other collaboratorsUnknownHeart Diseases | Rheumatic Heart Disease | Rheumatic Heart Disease in Children | Latent Rheumatic Heart DiseaseUganda
-
Assiut UniversityCompletedRheumatic; Heart Disease, Maternal, Affecting Fetus
-
African Academy of Methodology and StatisticsSuspendedRheumatic Heart Disease in ChildrenSenegal
-
University Hospital Inselspital, BerneRecruitingRheumatic Heart Disease | Rheumatic Heart Disease in ChildrenNepal
-
Beijing Anzhen HospitalRecruitingOutcomes of Mitral Valve Surgery in Patients Affected by Rheumatic Heart DiseaseChina
-
University of WashingtonNational Heart, Lung, and Blood Institute (NHLBI); Manmohan Cardiothoracic...Active, not recruitingRheumatic Heart Disease | Valvular DiseaseNepal
-
University of Sao Paulo General HospitalNot yet recruitingClinical Trial Phase I/IIa to Evaluate the Safety and Immunogenicity of StreptInCor (StreptInCorVac)Vaccine Adverse Reaction | Rheumatic Diseases | Rheumatic Heart Disease | Vaccine | Rheumatic Heart Disease in Children | Vaccine AcceptanceBrazil
-
Yahia Abd almonem SayedNot yet recruitingRheumatic Heart Disease With Valvulitis
-
University Hospital Inselspital, BerneInstituto de Cardiología Paredes-Horna, Arequipa; Hospital Nacional Carlos...CompletedRheumatic Heart Disease | Acute Rheumatic FeverPeru, Switzerland
Clinical Trials on Primary Training Phase
-
University of ThessalyCompletedOverweight and ObesityGreece
-
Brigham and Women's HospitalUniversity of Pennsylvania; Breast Cancer Research Foundation; Ministry of Health... and other collaboratorsCompleted
-
Universidad de AlmeriaHospital Universitario Virgen de la Arrixaca; Catholic University of MurciaActive, not recruitingMultiple Sclerosis (MS) - Relapsing-remittingSpain
-
US Department of Veterans AffairsCompletedOropharyngeal Dysphagia | Oropharyngeal CancerUnited States
-
Cambridge Health AllianceNational Center for Complementary and Integrative Health (NCCIH)TerminatedDepression | Anxiety Disorders | Adjustment Disorders | Chronic Illness | Stress Related DisorderUnited States
-
Cambridge Health AllianceBrown University; National Center for Complementary and Integrative Health... and other collaboratorsTerminated
-
Virginia Commonwealth UniversityOrganization for Autism ResearchCompletedAutismUnited States
-
University Medical Centre LjubljanaRecruitingCoronary Artery Disease With Myocardial InfarctionSlovenia
-
Cambridge Health AllianceBrown University; National Center for Complementary and Integrative Health... and other collaboratorsCompletedDepression | Anxiety | Psychiatric Problem | Neuroimaging | Self-ControlUnited States
-
Northwestern UniversityNorthwestern Memorial HospitalCompletedHead and Neck Cancer | Dysphagia | Oropharyngeal Dysphagia | Oropharynx Squamous Cell CarcinomaUnited States